Prognostic Markers of Overall Survival in Cancer Patients Attending a Cachexia Support Service: An Evaluation of Clinically Assessed Physical Function, Malnutrition and Inflammatory Status

References

• Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO, Engstrom PF, Ezdinli EZ, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980;69(4):491–7. doi:10.1016/s0149-2918(05)80001-3
   PubMed Web of Science ®Google Scholar
• Martin L, Senesse P, Gioulbasanis I, Antoun S, Bozzetti F, Deans C, Strasser F, Thoresen L, Jagoe RT, Chasen M, et al. Diagnostic criteria for the classification of cancer-associated weight loss. JCO. 2015;33(1):90–9. doi:10.1200/JCO.2014.56.1894
   PubMed Web of Science ®Google Scholar
• Caillet P, Liuu E, Raynaud Simon A, Bonnefoy M, Guerin O, Berrut G, Lesourd B, Jeandel C, Ferry M, Rolland Y, et al. Association between cachexia, chemotherapy and outcomes in older cancer patients: A systematic review. Clin Nutr. 2017;36(6):1473–82. doi:10.1016/j.clnu.2016.12.003
   PubMed Web of Science ®Google Scholar
• Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, et al. Definition and classification of cancer cachexia: An international consensus. Lancet Oncol. 2011;12(5):489–95. doi:10.1016/S1470-2045(10)70218-7
   PubMed Web of Science ®Google Scholar
• Baracos VE, Mazurak VC, Bhullar AS. Cancer cachexia is defined by an ongoing loss of skeletal muscle mass. Ann Palliat Med. 2019;8(1):3–12. doi:10.21037/apm.2018.12.01
   PubMed Web of Science ®Google Scholar
• Kimura M, Naito T, Kenmotsu H, Taira T, Wakuda K, Oyakawa T, Hisamatsu Y, Tokito T, Imai H, Akamatsu H, et al. Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer. Support Care Cancer. 2015;23(6):1699–708. doi:10.1007/s00520-014-2534-3
   PubMed Web of Science ®Google Scholar
• Mytelka DS, Li L, Benoit K. Post-diagnosis weight loss as a prognostic factor in non-small cell lung cancer. J Cachexia Sarcopenia Muscle. 2018;9(1):86–92. doi:10.1002/jcsm.12253
   PubMed Web of Science ®Google Scholar
• Gibson DJ, Burden ST, Strauss BJ, Todd C, Lal S. The role of computed tomography in evaluating body composition and the influence of reduced muscle mass on clinical outcome in abdominal malignancy: A systematic review. Eur J Clin Nutr. 2015;69(10):1079–86. doi:10.1038/ejcn.2015.32
   PubMed Web of Science ®Google Scholar
• Pamoukdjian F, Bouillet T, Lévy V, Soussan M, Zelek L, Paillaud E. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review. Clin Nutr. 2018;37(4):1101–13. doi:10.1016/j.clnu.2017.07.010
   PubMed Web of Science ®Google Scholar
• Kazemi-Bajestani SM, Mazurak VC, Baracos V. Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes. Semin Cell Dev Biol. 2016;54:2–10. doi:10.1016/j.semcdb.2015.09.001
   PubMed Web of Science ®Google Scholar
• Ryan AM, Prado CM, Sullivan ES, Power DG, Daly LE. Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival. Nutrition. 2019;67-68:110539. doi:10.1016/j.nut.2019.06.020
   PubMed Web of Science ®Google Scholar
• Bye A, Sjøblom B, Wentzel-Larsen T, Grønberg BH, Baracos VE, Hjermstad MJ, Aass N, Bremnes RM, Fløtten Ø, Jordhøy M, et al. Muscle mass and association to quality of life in non-small cell lung cancer patients. J Cachexia Sarcopenia Muscle. 2017;8(5):759–67. doi:10.1002/jcsm.12206
   PubMed Web of Science ®Google Scholar
• Naito T, Okayama T, Aoyama T, Ohashi T, Masuda Y, Kimura M, Shiozaki H, Murakami H, Kenmotsu H, Taira T, et al. Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly japanese patients with advanced non-small-cell lung cancer. BMC Cancer. 2017;17(1):571. doi:10.1186/s12885-017-3562-4
   PubMed Web of Science ®Google Scholar
• Vigano AAL, Morais JA, Ciutto L, Rosenthall L, di Tomasso J, Khan S, Olders H, Borod M, Kilgour RD. Use of routinely available clinical, nutritional, and functional criteria to classify cachexia in advanced cancer patients. Clin Nutr. 2017;36(5):1378–90. doi:10.1016/j.clnu.2016.09.008
   PubMed Web of Science ®Google Scholar
• Ozorio GA, Barao K, Forones NM. Cachexia stage, patient-generated subjective global assessment, phase angle, and handgrip strength in patients with gastrointestinal cancer. Nutr Cancer. 2017;69(5):772–9. doi:10.1080/01635581.2017.1321130
   PubMed Web of Science ®Google Scholar
• Guinan EM, Doyle SL, Bennett AE, O'Neill L, Gannon J, Elliott JA, O'Sullivan J, Reynolds JV, Hussey J. Sarcopenia during neoadjuvant therapy for oesophageal cancer: Characterising the impact on muscle strength and physical performance. Support Care Cancer. 2018;26(5):1569–76. doi:10.1007/s00520-017-3993-0
   PubMed Web of Science ®Google Scholar
• Takayama K, Atagi S, Imamura F, Tanaka H, Minato K, Harada T, Katakami N, Yokoyama T, Yoshimori K, Takiguchi Y, et al. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study. Support Care Cancer. 2016;24(8):3473–80. doi:10.1007/s00520-016-3156-8
   PubMed Web of Science ®Google Scholar
• Wallengren O, Lundholm K, Bosaeus I. Diagnostic criteria of cancer cachexia: Relation to quality of life, exercise capacity and survival in unselected palliative care patients. Support Care Cancer. 2013;21(6):1569–77. doi:10.1007/s00520-012-1697-z
   PubMed Web of Science ®Google Scholar
• Naito T, Okayama T, Aoyama T, Ohashi T, Masuda Y, Kimura M, Shiozaki H, Murakami H, Kenmotsu H, Taira T, et al. Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: A prospective longitudinal observational study. BMC Cancer. 2017;17(1):800. doi:10.1186/s12885-017-3795-2
   PubMed Web of Science ®Google Scholar
• Kilgour RD, Vigano A, Trutschnigg B, Lucar E, Borod M, Morais JA. Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients. Support Care Cancer. 2013;21(12):3261–70. doi:10.1007/s00520-013-1894-4
   PubMed Web of Science ®Google Scholar
• Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: A prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer. 1996;32(7):1135–41. doi:10.1016/0959-8049(95)00664-8
   Web of Science ®Google Scholar
• Hwang SS, Scott CB, Chang VT, Cogswell J, Srinivas S, Kasimis B. Prediction of survival for advanced cancer patients by recursive partitioning analysis: Role of Karnofsky Performance Status, quality of life, and symptom distress. Cancer Invest. 2004;22(5):678–87. doi:10.1081/CNV-200032911
   PubMed Web of Science ®Google Scholar
• Gripp S, Moeller S, Bölke E, Schmitt G, Matuschek C, Asgari S, Asgharzadeh F, Roth S, Budach W, Franz M, et al. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. JCO. 2007;25(22):3313–20. doi:10.1200/JCO.2006.10.5411
   PubMed Web of Science ®Google Scholar
• Carvalho CS, Souza DS, Lopes JR, Castanho IA, Lopes AJ. Relationship between Patient-Generated Subjective Global Assessment and survival in patients in palliative care. Ann Palliat Med. 2017;6(S1):S4–S12. doi:10.21037/apm.2017.03.03
   PubMed Web of Science ®Google Scholar
• Brown JC, Harhay MO, Harhay MN. Physical function as a prognostic biomarker among cancer survivors. Br J Cancer. 2015;112(1):194–8. doi:10.1038/bjc.2014.568
   PubMed Web of Science ®Google Scholar
• Jones LW, Hornsby WE, Goetzinger A, Forbes LM, Sherrard EL, Quist M, Lane AT, West M, Eves ND, Gradison M, et al. Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer. Lung Cancer. 2012;76(2):248–52. doi:10.1016/j.lungcan.2011.10.009
   PubMed Web of Science ®Google Scholar
• Kasymjanova G, Correa JA, Kreisman H, Dajczman E, Pepe C, Dobson S, Lajeunesse L, Sharma R, Small D. Prognostic value of the six-minute walk in advanced non-small cell lung cancer. J Thorac Oncol. 2009;4(5):602–7. doi:10.1097/JTO.0b013e31819e77e8
   PubMed Web of Science ®Google Scholar
• Burtin C, Bezuidenhout J, Sanders KJC, Dingemans A‐MC, Schols AMWJ, Peeters STH, Spruit MA, De Ruysscher DKM. Handgrip weakness, low fat-free mass, and overall survival in non-small cell lung cancer treated with curative-intent radiotherapy. J Cachexia Sarcopenia Muscle. 2020;11(2):424–31. doi:10.1002/jcsm.12526
   PubMed Web of Science ®Google Scholar
• Celis-Morales CA, Welsh P, Lyall DM, Steell L, Petermann F, et al. Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: Prospective cohort study of half a million UK biobank participants. BMJ. 2018;361:k1651.
   PubMed Web of Science ®Google Scholar
• Klepin HD, Geiger AM, Tooze JA, Newman AB, Colbert LH, Bauer DC, Satterfield S, Pavon J, Kritchevsky SB, Health, Aging and Body Composition Study Physical performance and subsequent disability and survival in older adults with malignancy: Results from the health, aging and body composition study. J Am Geriatr Soc. 2010;58(1):76–82. doi:10.1111/j.1532-5415.2009.02620.x
   PubMed Web of Science ®Google Scholar
• Vagnildhaug OM, Balstad TR, Almberg SS, Brunelli C, Knudsen AK, Kaasa S, Thronaes M, Laird B, Solheim TS. A cross-sectional study examining the prevalence of cachexia and areas of unmet need in patients with cancer. Support Care Cancer. 2018;26(6):1871–80. doi:10.1007/s00520-017-4022-z
   PubMed Web of Science ®Google Scholar
• Pergolotti M, Deal AM, Williams GR, Bryant AL, Bensen JT, Muss HB, Reeve BB. Activities, function, and health-related quality of life (HRQOL) of older adults with cancer. J Geriatr Oncol. 2017;8(4):249–54. doi:10.1016/j.jgo.2017.02.009
   PubMed Web of Science ®Google Scholar
• Ando M, Ando Y, Hasegawa Y, Shimokata K, Minami H, Wakai K, Ohno Y, Sakai S. Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer. Br J Cancer. 2001;85(11):1634–9. doi:10.1054/bjoc.2001.2162
   PubMed Web of Science ®Google Scholar
• Schnadig ID, Fromme EK, Loprinzi CL, Sloan JA, Mori M, Li H, Beer TM. Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer. Cancer. 2008;113(8):2205–14. doi:10.1002/cncr.23856
   PubMed Web of Science ®Google Scholar
• Wheelwright S, Darlington AS, Hopkinson JB, Fitzsimmons D, Johnson C. A systematic review and thematic synthesis of quality of life in the informal carers of cancer patients with cachexia. Palliat Med. 2016;30(2):149–60. doi:10.1177/0269216315588743
   PubMed Web of Science ®Google Scholar
• Zhou T, Yang K, Thapa S, Liu H, Wang B, Yu S. Differences in symptom burden among cancer patients with different stages of cachexia. J Pain Symptom Manage. 2017;53(5):919–26. doi:10.1016/j.jpainsymman.2016.12.325
   PubMed Web of Science ®Google Scholar
• Souza Cunha M, Wiegert EVM, Calixto-Lima L, Oliveira LC. Relationship of nutritional status and inflammation with survival in patients with advanced cancer in palliative care. Nutrition. 2018;51-52:98–103. doi:10.1016/j.nut.2017.12.004
   PubMed Web of Science ®Google Scholar
• Tan CSY, Read JA, Phan VH, Beale PJ, Peat JK, Clarke SJ. The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: A prospective cohort study. Support Care Cancer. 2015;23(2):385–91. doi:10.1007/s00520-014-2385-y
   PubMed Web of Science ®Google Scholar
• Srdic D, Plestina S, Sverko-Peternac A, Nikolac N, Simundic A-M, Samarzija M. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value. Support Care Cancer. 2016;24(11):4495–502. doi:10.1007/s00520-016-3287-y
   PubMed Web of Science ®Google Scholar
• Wiegert EVM, Padilha PC, Peres WAF. Performance of Patient-Generated Subjective Global Assessment (PG-SGA) in patients with advanced cancer in palliative care. Nutr Clin Pract. 2017;32(5):675–81. doi:10.1177/0884533617725071
   PubMed Web of Science ®Google Scholar
• Martin L, Watanabe S, Fainsinger R, Lau F, Ghosh S, Quan H, Atkins M, Fassbender K, Downing GM, Baracos V, et al. Prognostic factors in patients with advanced cancer: Use of the Patient-Generated Subjective Global Assessment in survival prediction. JCO. 2010;28(28):4376–83. doi:10.1200/JCO.2009.27.1916
   PubMed Web of Science ®Google Scholar
• Read JA, Choy ST, Beale PJ, Clarke SJ. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer. 2006;55(1):78–85. doi:10.1207/s15327914nc5501_10
   PubMed Web of Science ®Google Scholar
• Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr. 2002;56(8):779–85. doi:10.1038/sj.ejcn.1601412
   PubMed Web of Science ®Google Scholar
• Bilir C, Engin H, Can M, Temi YB, Demirtas D. The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia. Med Oncol. 2015;32(3):56. doi:10.1007/s12032-015-0497-y
   PubMed Web of Science ®Google Scholar
• Utech AE, Tadros EM, Hayes TG, Garcia JM. Predicting survival in cancer patients: The role of cachexia and hormonal, nutritional and inflammatory markers. J Cachexia Sarcopenia Muscle. 2012;3(4):245–51. doi:10.1007/s13539-012-0075-5
   PubMed Web of Science ®Google Scholar
• Vaughan VC, Farrell H, Lewandowski PA, McCoombe SG, Martin P. Defining a new model of interdisciplinary cancer cachexia care in regional Victoria, Australia. Support Care Cancer. 2020;28(7):3041–9. Epub ahead of print 12 Oct doi:10.1007/s00520-019-05072-w
   PubMed Web of Science ®Google Scholar
• Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999;70(2):113–9. doi:10.1080/02701367.1999.10608028
   PubMed Web of Science ®Google Scholar
• Bruun IH, Mogensen CB, Norgaard B, Schiottz-Christensen B, Maribo T. Validity and responsiveness to change of the 30-second chair-stand test in older adults admitted to an emergency department. J Geriatr Phys Ther. 2019;42(4):265–74.
   PubMed Web of Science ®Google Scholar
• Spruit MA, Sillen MJ, Groenen MT, Wouters EF, Franssen FM. New normative values for handgrip strength: Results from the UK biobank. J Am Med Dir Assoc. 2013;14(10):775.e5–775.e11. doi:10.1016/j.jamda.2013.06.013
   PubMed Web of Science ®Google Scholar
• Ottery FD. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition. 1996;12(1 Suppl):S15–S19. doi:10.1016/0899-9007(95)00067-4
   PubMed Web of Science ®Google Scholar
• Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, de Graeff A, Hammerlid E, Kaasa S, EORTC Quality of Life Group, et al. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer. 2006;42(1):55–64. doi:10.1016/j.ejca.2005.06.022
   PubMed Web of Science ®Google Scholar
• Ribaudo JM, Cella D, Hahn EA, Lloyd SR, Tchekmedyian NS, Von Roenn J, Leslie WT. Re-validation and shortening of the functional assessment of anorexia/cachexia therapy (FAACT) questionnaire. Qual Life Res. 2000;9(10):1137–46. doi:10.1023/a:1016670403148
   PubMed Web of Science ®Google Scholar
• Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332(9):556–61. doi:10.1056/NEJM199503023320902
   PubMed Web of Science ®Google Scholar
• Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB. A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85–94. doi:10.1093/geronj/49.2.M85
   PubMedGoogle Scholar
• Cesari M, Onder G, Zamboni V, Manini T, Shorr RI, Russo A, Bernabei R, Pahor M, Landi F. Physical function and self-rated health status as predictors of mortality: Results from longitudinal analysis in the ilsirente study. BMC Geriatr. 2008;8:34. doi:10.1186/1471-2318-8-34
   PubMedGoogle Scholar
• Studenski S, Perera S, Patel K, Rosano C, Faulkner K, et al. Gait speed and survival in older adults. JAMA. 2011;305(1):50–8. doi:10.1001/jama.2010.1923
   PubMed Web of Science ®Google Scholar
• Ostir GV, Kuo YF, Berges IM, Markides KS, Ottenbacher KJ. Measures of lower body function and risk of mortality over 7 years of follow-up. Am J Epidemiol. 2007;166(5):599–605. doi:10.1093/aje/kwm121
   PubMed Web of Science ®Google Scholar
• García-Hermoso A, Ramírez-Vélez R, Peterson MD, Lobelo F, Cavero-Redondo I, Correa-Bautista JE, Martínez-Vizcaíno V. Handgrip and knee extension strength as predictors of cancer mortality: A systematic review and meta-analysis. Scand J Med Sci Sports. 2018;28(8):1852–8. doi:10.1111/sms.13206
   PubMed Web of Science ®Google Scholar
• Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol. 2013;10(2):90–9. doi:10.1038/nrclinonc.2012.209
   PubMed Web of Science ®Google Scholar
• Dev R, Hui D, Chisholm G, Delgado-Guay M, Dalal S, Del Fabbro E, Bruera E. Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic. J Cachexia Sarcopenia Muscle. 2015;6(1):95–8. doi:10.1002/jcsm.12014
   PubMed Web of Science ®Google Scholar
• Vazeille C, Jouinot A, Durand J-P, Neveux N, Boudou-Rouquette P, Huillard O, Alexandre J, Cynober L, Goldwasser F. Relation between hypermetabolism, cachexia, and survival in cancer patients: A prospective study in 390 cancer patients before initiation of anticancer therapy. Am J Clin Nutr. 2017;105(5):1139–47. doi:10.3945/ajcn.116.140434
   PubMed Web of Science ®Google Scholar
• Dolan RD, McSorley ST, Horgan PG, Laird B, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta-analysis. Crit Rev Oncol Hematol. 2017;116:134–46. doi:10.1016/j.critrevonc.2017.06.002
   PubMed Web of Science ®Google Scholar
• Cavalcante Martins FF, de Pinho NB, de Carvalho Padilha P, Martucci RB, Rodrigues VD, Sales RC, Ferreira Peres WA. Subjective Global Assessment predicts cachexia and death in patients with head, neck and abdominal cancer: A retrospective longitudinal study. Clin Nutr ESPEN. 2019;31:17–22. doi:10.1016/j.clnesp.2019.03.013
   PubMed Web of Science ®Google Scholar
• de Oliveira LC, Abreu GT, Lima LC, Aredes MA, Wiegert EVM. Quality of life and its relation with nutritional status in patients with incurable cancer in palliative care. Support Care Cancer. 2020. Epub ahead of print 7 Feb 2020; doi:10.1007/s00520-020-05339-7
   Web of Science ®Google Scholar
• Stene GB, Balstad TR, Leer ASM, Bye A, Kaasa S, Fallon M, Laird B, Maddocks M, Solheim TS. Deterioration in muscle mass and physical function differs according to weight loss history in cancer cachexia. Cancers (Basel). 2019;11(12):1925. doi:10.3390/cancers11121925
   PubMed Web of Science ®Google Scholar
• Gale N, Wasley D, Roberts S, Backx K, Nelson A, van Deursen R, Byrne A. A longitudinal study of muscle strength and function in patients with cancer cachexia. Support Care Cancer. 2019;27(1):131–7. doi:10.1007/s00520-018-4297-8
   PubMed Web of Science ®Google Scholar